Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler
other · Rule · Interim final rule. · Published 2015-10-27 · 80 FR 65632
Document
Document number
2015-27264
Federal Register citation
80 FR 65632
Type
Rule
Action
Interim final rule.
Category
other
Publication date
2015-10-27
Abstract
The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the company name for the drug product Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 milligrams levmetamfetamine) to Aphena Pharma Solutions--New York, LLC. This over-the-counter, nonnarcotic drug product is excluded from the provisions of the Controlled Substances Act.